Altimmune, Inc.
ALT
$3.93
$0.000.00%
NASDAQ
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | 0.00% | 0.00% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 0.00% | 0.00% | |||
Cost of Revenue | 8.90% | -19.99% | |||
Gross Profit | -8.91% | 19.99% | |||
SG&A Expenses | -5.04% | 17.74% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 5.07% | -12.27% | |||
Operating Income | -5.07% | 12.27% | |||
Income Before Tax | -9.33% | 12.61% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -13.13% | 15.55% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -13.13% | 15.55% | |||
EBIT | -5.07% | 12.27% | |||
EBITDA | -5.08% | 12.27% | |||
EPS Basic | -4.90% | 20.35% | |||
Normalized Basic EPS | -1.37% | 17.56% | |||
EPS Diluted | -4.90% | 20.35% | |||
Normalized Diluted EPS | -1.37% | 17.56% | |||
Average Basic Shares Outstanding | 7.85% | 6.02% | |||
Average Diluted Shares Outstanding | 7.85% | 6.02% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |